Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 5,000 shares at $28.13 ($141K) on 2026-05-15, disclosed to the SEC on 2026-05-18.
Open-market sale of $141k ATRC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2025-05-30 | $84K | — | Filing → |
| ATRC | SELL | 2022-09-19 | $458K | — | Filing → |